CXCR4 and neoplasm: In contrast to that observed in immunodeficient mice, tumor growth was not significantly blocked after CXCR4 abrogation (Fig. 3b; Supplementary Fig. 3I), or after AMD3100 treatment (Fig. 3c), suggesting that the effect of CXCR4 inhibition on tumor growth may be tumor microenvironment-dependent.